(a) All British Columbians who were implanted with one or more mechanical heart valves, or annuloplasty rings, coated with Silzone® that were designed, manufactured, marketed, distributed or sold by the Defendants (the “Patient Class”); and

(b) All British Columbians who would otherwise be entitled to damages pursuant to the provisions of the Family Compensation Act as a result of the death of a family member related to the implant of an SJM Silzone-coated device (the ”Family Compensation Act Class”); and

(c) All British Columbians who have suffered loss and expense in the provision of care, rehabilitation and other services to a family member who has been implanted with an SJM Silzone-coated device (the “Family Class”).